Menu
GeneBe

3-157437846-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002852.4(PTX3):c.464A>G(p.Glu155Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000127 in 1,496,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

PTX3
NM_002852.4 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.64
Variant links:
Genes affected
PTX3 (HGNC:9692): (pentraxin 3) This gene encodes a member of the pentraxin protein family. The expression of this protein is induced by inflammatory cytokines in response to inflammatory stimuli in several mesenchymal and epithelial cell types, particularly endothelial cells and mononuclear phagocytes. The protein promotes fibrocyte differentiation and is involved in regulating inflammation and complement activation. It also plays a role in angiogenesis and tissue remodeling. The protein serves as a biomarker for several inflammatory conditions. [provided by RefSeq, Jun 2016]
VEPH1 (HGNC:25735): (ventricular zone expressed PH domain containing 1) Predicted to enable phosphatidylinositol-5-phosphate binding activity. Involved in negative regulation of SMAD protein signal transduction and negative regulation of transforming growth factor beta receptor signaling pathway. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14263618).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTX3NM_002852.4 linkuse as main transcriptc.464A>G p.Glu155Gly missense_variant 2/3 ENST00000295927.4
VEPH1NM_001167912.2 linkuse as main transcriptc.530-9358T>C intron_variant ENST00000362010.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTX3ENST00000295927.4 linkuse as main transcriptc.464A>G p.Glu155Gly missense_variant 2/31 NM_002852.4 P1
VEPH1ENST00000362010.7 linkuse as main transcriptc.530-9358T>C intron_variant 1 NM_001167912.2 P1Q14D04-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151916
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000338
AC:
3
AN:
88762
Hom.:
0
AF XY:
0.0000197
AC XY:
1
AN XY:
50686
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000603
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000304
Gnomad OTH exome
AF:
0.000364
GnomAD4 exome
AF:
0.0000134
AC:
18
AN:
1344704
Hom.:
0
Cov.:
35
AF XY:
0.0000136
AC XY:
9
AN XY:
663584
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000349
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000132
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000939
Gnomad4 OTH exome
AF:
0.000107
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151916
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74206
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000870
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000128
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 17, 2023The c.464A>G (p.E155G) alteration is located in exon 2 (coding exon 2) of the PTX3 gene. This alteration results from a A to G substitution at nucleotide position 464, causing the glutamic acid (E) at amino acid position 155 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
Cadd
Benign
23
Dann
Uncertain
0.99
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
M
MutationTaster
Benign
0.95
D;D;D;D;D
PrimateAI
Pathogenic
0.88
D
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.092
Sift
Benign
0.071
T
Sift4G
Uncertain
0.048
D
Polyphen
0.013
B
Vest4
0.43
MutPred
0.37
Gain of MoRF binding (P = 0.0199);
MVP
0.37
MPC
0.46
ClinPred
0.099
T
GERP RS
4.5
Varity_R
0.16
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs770594285; hg19: chr3-157155635; API